How do I find recruiting Cancer clinical trials?

Browse the actively recruiting Cancer studies listed on this page, or take an assessment to see trials you may qualify for based on your profile.

Are Cancer clinical trials free to join?

Costs, travel support, and any payment for taking part vary by study. Ask the study team what is covered before you decide to join.

Who can take part in a Cancer clinical trial?

Each study has its own eligibility criteria (for example age, disease stage, and prior treatments). This page is general information and not medical advice; discuss any specific trial with your healthcare provider to confirm whether it is appropriate for you.

Cancer Clinical Trials

Cancer clinical trials evaluate new drugs, immunotherapies, radiation approaches, and combination treatments for cancer. Corterve aggregates actively recruiting Cancer studies from the public ClinicalTrials.gov registry so you can browse them by location and eligibility. Many oncology trials enroll patients at different stages of disease, including newly diagnosed and previously treated. This is general information, not medical advice — review any study with your oncology care team before enrolling.

Browse all Cancer trials Take the assessment

Recruiting Cancer studies

Phase 3 Study of Toripalimab Alone or in Combination With Tifcemalimab as Consolidation Therapy in Patients With Limited-stage Small Cell Lung Cancer (LS-SCLC)
NCT06095583PHASE3Shanghai Junshi Bioscience Co., Ltd.Limited-stage Small Cell Lung Cancer (LS-SCLC)Goodyear, Arizona
Rare Tumors and Cancer Predisposition in Individuals and Families
NCT05350761National Cancer Institute (NCI)CancerBethesda, Maryland
A Study to Compare Setidegrasib (ASP3082) With Docetaxel, in People With Non-small Cell Lung Cancer With a KRAS G12D Mutation
NCT07566052PHASE3Astellas Pharma Global Development, Inc.Non-small Cell Lung Cancer (NSCLC)Glendale, California
Evaluation of Cell Changes in Blood and Tissue in Cancers of the Lung, Esophagus and Lung Lining
NCT00242723National Cancer Institute (NCI)Thoracic CancersBethesda, Maryland
A Study to Assess Adverse Events and Change in Disease Activity of Multiple Treatment Combinations With Intravenous Mirvetuximab Soravtansine in Adult Participants With Ovarian Cancer
NCT07059845PHASE2AbbVieOvarian CancerLa Jolla, California
Extending Outcomes for Pancreas Cancer Patients With Nominal Oligometastatic Disease (EXPAND): A Randomized Phase III Trial
NCT06593431PHASE3M.D. Anderson Cancer CenterPancreas CancerCamden, New Jersey
A Study to Test Inavolisib Treatment in Participants With Metastatic Castration-Resistant Prostate Cancer
NCT07287150PHASE2Hoffmann-La RocheMetastatic Castration-Resistant Prostate CancerLos Angeles, California
Symbiotic-Lung-04: A Study to Learn About the Study Medicine Called PF-08634404 in Combination With Chemotherapy in Adult Participants With Extensive-Stage Small Cell Lung Cancer
NCT07226999PHASE2, PHASE3PfizerSmall Cell Lung Cancer (SCLC)Fayetteville, Arkansas
A Study of Opevesostat (MK-5684) Versus Alternative Next-generation Hormonal Agent (NHA) in Metastatic Castration-resistant Prostate Cancer (mCRPC) Post One NHA (MK-5684-004)
NCT06136650PHASE3Merck Sharp & Dohme LLCMetastatic Castration-resistant Prostate Cancer (mCRPC)Tucson, Arizona
Symbiotic-GI-16: A Study to Learn About the Study Medicine Called PF-08634404 in Combination With Chemotherapy in Gastroesophageal Cancer
NCT07392892PHASE2, PHASE3PfizerUntreated Advanced or Metastatic Gastric, Gastroesophageal Junction , or Esophageal AdenocarcinomaAtascadero, California
A Study to Evaluate the Effect of GDC-4198 Alone and in Combination With Giredestrant Versus Abemaciclib and Giredestrant in Participants With Locally Advanced or Metastatic Estrogen Receptor-Positive (ER+), Human Epidermal Growth Factor Receptor-Negative (HER2-) Breast Cancer
NCT07100106PHASE1, PHASE2Genentech, Inc.Breast CancerHuntsville, Alabama
Sacituzumab Tirumotecan (MK-2870) Plus Pembrolizumab Versus TPC in TNBC Who Did Not Achieve pCR (MK-2870-012)
NCT06393374PHASE3Merck Sharp & Dohme LLCTriple-Negative Breast CancerMobile, Alabama

See all 3,303 recruiting trials →

Cancer trials by state

Cancer trials by metro

Frequently asked questions

How do I find recruiting Cancer clinical trials?: Browse the actively recruiting Cancer studies listed on this page, or take an assessment to see trials you may qualify for based on your profile.
Are Cancer clinical trials free to join?: Costs, travel support, and any payment for taking part vary by study. Ask the study team what is covered before you decide to join.
Who can take part in a Cancer clinical trial?: Each study has its own eligibility criteria (for example age, disease stage, and prior treatments). This page is general information and not medical advice; discuss any specific trial with your healthcare provider to confirm whether it is appropriate for you.